GENERAL
Novartis India Terminates Sales Pact With Dr Reddy’s For Key Medicines
Novartis India Ltd has decided to terminate its exclusive distribution and promotion agreement with Dr. Reddy’s Laboratories Ltd (DRL), bringing an end to a strategic partnership signed in 2022 for the marketing and sale of several established medicine brands in India. The company’s Board of Directors has approved the termination of the distribution and promotion […]
Sajan C Kumar
·
Aug 7, 2026
GENERAL
Sun Pharma To Acquire Innovcare For ₹271 Cr To Bolster Product Portfolio
Sun Pharmaceutical Industries has signed an agreement to acquire 100% of Mumbai-based Innovcare Lifesciences Pvt Ltd for ₹271 crore in cash, strengthening its product portfolio in the pharmaceuticals, nutraceuticals and cosmeceuticals segments. The pharmaceutical company informed stock exchanges on Saturday that the acquisition will be completed on or before July 31, 2026. The transaction is […]
CW Bureau
·
Jun 20, 2026
GENERAL
Indian Pharma Firms To Gain Up To $5 Bn From Global Patent Cliff: CareEdge
Indian pharmaceutical companies are poised to benefit from a major global patent expiry cycle, with drugs generating nearly $142 billion in sales in CY25 set to lose exclusivity between 2026 and 2030, according to a report by CareEdge Ratings. The report estimates that the upcoming patent cliff could create a market opportunity of over $30-40 […]
CW Bureau
·
Jun 19, 2026
